OCT1 polymorphism is associated with response and survival time in anti-Parkinsonian drug users (Q34534509)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | OCT1 polymorphism is associated with response and survival time in anti-Parkinsonian drug users |
scientific article |
Statements
Albert Hofman
Matthijs L Becker
Loes E Visser
Ron H N van Schaik
1 reference